About Twist Bioscience Corp
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.twistbioscience.com/
Frequently Asked Questions
What is the 52-week range for TWST?
The 52-week high is $200.31 and the 52-week low is $23.3.
What is the P/E ratio for TWST?
The P/E ratio data is currently unavailable.
What is the dividend yield for TWST?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -29.89%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -31.66%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 3.59.
Analyst Recommendation Trends
Wall Street analyst consensus for TWST over the last few months:
Latest TWST News
Twist Bioscience (TWST) Stock Fair Value Edges Higher As Analysts Split On AI Upside
Twist Bioscience has seen its assessed fair value move from US$105.30 to US$109.58, a modest reset that feeds into how analysts frame the stock’s price targets. The shift comes as research coverage splits between those pointing to higher peer comparables and AI driven drug discovery potential, and others who argue that recent gains and event driven enthusiasm already price in a lot of good news. In the sections that follow, you will see how these changing targets fit into the broader Twist...
Twist Bioscience (TWST) Stock Could Be Reasonable On Its 9x Three Year Run
Twist Bioscience has turned into one of the market’s stronger long term performers, and the latest surge leaves a simple but important question on the table. Do the company’s current cash flows and their future potential really support today’s share price around US$188? Over the past 3 years, Twist Bioscience has delivered a gain of about 9x, which puts a lot of pressure on its cash flows to justify how far the stock has already run. The new collaboration with Eli Lilly’s TuneLab ties Twist...
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
Towards Healthcare projects that the global AI in drug discovery market will grow from $19.89 billion in 2025 to $160.49 billion by 2035, a compound annual growth rate of 23.22%. Active Companies from around the markets with current developments this week include: MindWalk Holdings Corp. (NASDAQ: HYFT), AbCellera Biologics Inc. (NASDAQ: ABCL), Eli Lilly and Company (NYSE: LLY), Twist Bioscience Corporation (NASDAQ: TWST) and Tempus AI, Inc. (NASDAQ: TEM).
Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $212
Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $107 to $212.
The Top HealthTech Questions Landing On Our Desks
Strong performance across the healthtech sector over the past two quarters has sparked renewed market interest in medical innovation.
Leerink Partners Maintains Outperform on Twist Bioscience, Raises Price Target to $190
Leerink Partners analyst Puneet Souda maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $160 to $190.
Twist Bioscience: Don't Confuse A Short Squeeze With An AI Revolution
Twist Bioscience (TWST) surged on multiple expansion and AI hype, not fundamentals; AI revenue looks limited and valuation rich.
Foundayo’s Early Growth Is Raising Lilly (LLY)’s Revenue Expectations. But Can It Outrun Pricing Pressure?
Eli Lilly and Company (NYSE:LLY) received a modest price target raise on September 18 from Guggenheim. The brokerage increased its target to $1,284 from $1,273 while maintaining a Buy rating on the pharma stock. But perhaps the more important change was in Foundayo estimates. Guggenheim sharply raised its revenue forecasts for Lilly’s oral obesity drug, […]
What Needs To Be True To Buy Twist Bioscience Stock Now?
A $10,000 holding in Twist Bioscience (TWST) a year ago is worth about $66,600 today. The same sum in the S&P 500 would be worth about $11,700. The company sells made-to-order DNA to drug makers and research labs. Its sales grow fast, but it still loses money. The price now counts on that growth lasting and the losses ending. How much has to go right for that price to hold.
Twist Bioscience Stock Hits New High, Then Retreats: What's Happening?
Twist Bioscience shares are trading lower Friday, pulling back after touching a fresh 52-week high near $192 earlier in the session.
Twist Bioscience Stock Jumped 16% Thursday. Leerink Says Anthropic Made It Happen.
Key TakeawaysAnthropic Ripple: Twist Bioscience stock jumped 16% on Thursday, September 24, after Leerink Partners called the company the single most important beneficiary of Anthropic’s expanding biology research. Split Street: TIKR tracks 13 analysts: 7 buys, 2 outperforms, 3 holds, 1 sell.
Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership
Twist Bioscience Corporation (NASDAQ:TWST) is on the cusp of gaining significant exposure to the rapidly evolving artificial intelligence (AI)-driven drug discovery ecosystem. On September 16, the company confirmed a strategic partnership with Lilly TuneLab, a platform created by Eli Lilly and Company (NYSE:LLY). As part of the strategic partnership, Twist will provide antibody characterization data […]
September Stagnation Marked By Record-Low Yields, High Duration Risk And High Valuations
Over the first nine months of 2026, we have witnessed a fascinating macro paradox: a surging US stock market decoupling completely from the bond market. Read more here...
Practice Caution with This Hot Stock Up 493% in the Past Year
Twist Bioscience (TWST) has surged 493% over 52 weeks, maintaining strong technical momentum. Shares just hit a new all-time high and has a 100% “Buy” technical opinion. However, its RSI of 72.95 and high short interest signal potential overextension. Consensus price targets are well below current levels, suggesting limited upside....
Why Twist Bioscience Stock Skyrocketed This Week
It's plugging into a state-of-the-art research tool developed by a major pharmaceutical company.
DNA Synthesis Market Outlook 2026-2035 - Featuring Profiles of Leading Companies Integrated DNA Technologies, GenScript Biotech, and Twist Bioscience
DNA Synthesis Market Accelerates on Precision Medicine, Synthetic Biology and High-Throughput Automation DemandDublin, Sept. 18, 2026 (GLOBE NEWSWIRE) -- "DNA Synthesis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global DNA Synthesis Market to Reach USD 11.5 Billion by 2035, Driven by Synthetic Biology and Precision Medicine The global DNA synthesis market, valued at USD 2.5 billion in 2025, is projecte
TWST Stock Hits Multi-Year High, But ‘Pharma Bro’ Martin Shkreli Calls Twist A Short
Twist traded as high as $163.70 on Thursday and finished the session about 9% higher near $156.
HAE, TWST Stocks Jump To Over 5-Year Highs – What’s Driving The Gains Today?
Haemonetics and Twist Bioscience stocks surged to more than five-year highs on Thursday, as fresh growth opportunities drew cheer from Wall Street.
Vicor, Arm Holdings, Micron Technology And Other Big Stocks Moving Higher On Thursday
U.S. stocks rose; Vicor jumped 13.5% on a new license, while Generac surged 19.6% on an Amazon deal. Securitize and biotech shares rallied.
Twist Bioscience (TWST) Is Up 14.0% After Lilly AI Drug Discovery Tie-Up Is Announced - Has The Bull Case Changed?
On 16 September 2026, Twist Bioscience announced an agreement with Lilly TuneLab, under which Twist will provide antibody characterization data services using preferred Twist protocols to generate high-quality wet lab data that feed Lilly’s AI/ML drug discovery models. This collaboration effectively plugs Twist’s DNA and antibody capabilities into Lilly’s AI-driven discovery ecosystem, potentially deepening Twist’s role in data-rich, AI-enhanced antibody development workflows across the...
Sector Update: Healthcare Stocks Edge Lower Late Afternoon
Healthcare stocks were slightly lower late Wednesday afternoon, with the NYSE Healthcare Index fract
AI and Next-Gen Sequencing Strengthens Twist Bioscience Corp. (TWST)
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” second-quarter 2026 investor letter. The letter can be downloaded here. During the quarter, the Fund (Investor Shares) returned 17.49% (net of fees), outperforming the Russell 1000 Growth Index’s 16.74%. Holdings in Information Technology and Consumer Discretionary sectors boosted relative returns, while Communication Services […]
Sector Update: Healthcare Stocks Edge Higher Pre-Bell Wednesday
Healthcare stocks were edging higher pre-bell Wednesday, with the State Street Health Care Select Se
Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery
SOUTH SAN FRANCISCO, Calif., September 16, 2026--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced an agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly). Twist is a provider of antibody characterization data services for TuneLab, including for AbLab, an antibody developability prediction model.
Beyond Hype: Twist Bioscience Secures Data Pipeline Role In Eli Lilly TuneLab Ecosystem
Twist Bioscience joins Eli Lilly's TuneLab platform, supplying high-throughput antibody data to train advanced AI drug prediction models.
LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday
U.S. stocks mixed as Nasdaq rises; LuxExperience jumps 13.5% on strong sales, while Einride, Forgent, Cipher and others post gains.
AI And Robotics In 2026: 16 Recent Developments For Investors
If AI and robotics suddenly feel like they are moving faster, August gave investors plenty of evidence that the pace really is accelerating.
BWS Financial Initiates Coverage On Twist Bioscience with Sell Rating, Announces Price Target of $45
BWS Financial analyst Hamed Khorsand initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Sell rating and announces Price Target of $45.
Twist Bioscience to Present at Baird 2026 Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., September 09, 2026--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Adam Laponis, CFO of Twist Bioscience, will participate in a fireside chat at the Baird 2026 Global Healthcare Conference on Tuesday, September 15, 2026 at 1:25 pm Eastern Time in New York City.
UBS Initiates Coverage On Twist Bioscience with Neutral Rating, Announces Price Target of $144
UBS analyst Doug Schenkel initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Neutral rating and announces Price Target of $144.
Twist Bioscience (TWST) Rallied as AI and Pharma Drive DNA Demand
Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. The letter can be downloaded here. Global equities rebounded sharply in Q2 2026, recovering from March lows as resilient economic data, strong corporate earnings, and continued AI investment improved investor sentiment despite inflation concerns, delayed rate cuts, and […]
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
Equity Insider News Commentary - Pharmaceutical research is being rebuilt around artificial intelligence faster than the industry can absorb it. Arizton values the global AI in drug discovery market at approximately $1.71 billion in 2024 and projects it will reach roughly $8.52 billion by 2030, a compound annual growth rate of about 30.58%. That is a market compounding at more than double the rate of most enterprise software categories, and it is being spent inside an industry that already inves
The Market May Be Telling Us We're Entering A Capital Formation Cycle
My clustering stock screener is giving us a much more interesting macro signal than simply energy stocks are strong. The portfolio is not simply long commodities. It's long capital intensity
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-24 | Leproust Emily M. | -83 | $184.603 | $15,322 |
| 2026-09-24 | Leproust Emily M. | -501 | $183.7641 | $92,066 |
| 2026-09-24 | Leproust Emily M. | -16 | $182.5 | $2,920 |
| 2026-09-24 | Leproust Emily M. | -21 | $181.4519 | $3,810 |
| 2026-09-24 | Leproust Emily M. | -515 | $180.3911 | $92,901 |
| 2026-09-24 | Leproust Emily M. | -143 | $179.9331 | $25,730 |
| 2026-09-24 | Leproust Emily M. | -330 | $178.6683 | $58,961 |
| 2026-09-24 | Leproust Emily M. | -164 | $177.1699 | $29,056 |
| 2026-09-24 | Leproust Emily M. | -945 | $176.3917 | $166,690 |
| 2026-09-24 | Leproust Emily M. | -2,485 | $175.2313 | $435,450 |
| 2026-09-21 | Cho Dennis | -348 | $165.491 | $57,591 |
| 2026-09-21 | Green Paula | -294 | $165.491 | $48,654 |
| 2026-09-21 | Leproust Emily M. | -1,687 | $165.491 | $279,183 |
| 2026-09-17 | Leproust Emily M. | -133,269 | - | - |
| 2026-09-17 | Leproust Emily M. | -75,439 | - | - |
| 2026-09-17 | Leproust Emily M. | -869 | $163.3926 | $141,988 |
| 2026-09-17 | Leproust Emily M. | -2,565 | $162.3136 | $416,334 |
| 2026-09-17 | Leproust Emily M. | -11,169 | $161.493 | $1,803,715 |
| 2026-09-17 | Leproust Emily M. | -14,493 | $160.4392 | $2,325,245 |
| 2026-09-17 | Leproust Emily M. | -23,884 | $159.5315 | $3,810,250 |
| 2026-09-17 | Leproust Emily M. | -232,173 | $158.0876 | $36,703,672 |
| 2026-09-17 | Leproust Emily M. | -32,260 | $157.486 | $5,080,498 |
| 2026-09-17 | Leproust Emily M. | -9,097 | $156.4674 | $1,423,384 |
| 2026-09-17 | Leproust Emily M. | -13,378 | $155.4568 | $2,079,701 |
| 2026-09-17 | Leproust Emily M. | -4,175 | $154.1703 | $643,661 |
| 2026-09-17 | Leproust Emily M. | -3,399 | $153.4031 | $521,417 |
| 2026-09-17 | Leproust Emily M. | -6,644 | $152.2112 | $1,011,291 |
| 2026-09-17 | Leproust Emily M. | -2,440 | $151.4613 | $369,566 |
| 2026-09-17 | Leproust Emily M. | +75,439 | $8.82 | $665,372 |
| 2026-09-17 | Leproust Emily M. | +133,269 | $26.66 | $3,552,952 |
| 2026-09-08 | Cho Dennis | -412 | $122.624 | $50,521 |
| 2026-09-08 | Green Paula | -907 | $122.624 | $111,220 |
| 2026-09-08 | Leproust Emily M. | -2,302 | $122.624 | $282,280 |
| 2026-09-08 | WERNER ROBERT F. | -238 | $122.624 | $29,185 |
| 2026-08-25 | Leproust Emily M. | -1,093 | $154.446 | $168,809 |
| 2026-08-25 | Leproust Emily M. | -9,181 | $153.927 | $1,413,204 |
| 2026-08-25 | Leproust Emily M. | -6,412 | $152.75 | $979,433 |
| 2026-08-25 | Leproust Emily M. | -12,236 | $151.355 | $1,851,980 |
| 2026-08-25 | Leproust Emily M. | -12,648 | $150.564 | $1,904,333 |
| 2026-08-24 | WERNER ROBERT F. | -854 | $140.773 | $120,220 |
| 2026-08-21 | Cho Dennis | -1,598 | $139.066 | $222,227 |
| 2026-08-21 | Finn Patrick John | -4,046 | $139.066 | $562,661 |
| 2026-08-21 | Green Paula | -1,360 | $139.066 | $189,130 |
| 2026-08-21 | Laponis Adam | -1,965 | $139.066 | $273,265 |
| 2026-08-21 | Leproust Emily M. | -6,639 | $139.066 | $923,259 |
| 2026-08-21 | WERNER ROBERT F. | -669 | $139.066 | $93,035 |
| 2026-08-19 | Cho Dennis | -14,205 | $129.75 | $1,843,099 |
| 2026-08-18 | Finn Patrick John | -23,355 | - | - |
| 2026-08-18 | Finn Patrick John | -2,000 | $122.581 | $245,162 |
| 2026-08-18 | Finn Patrick John | -6,296 | $121.007 | $761,860 |
| 2026-08-18 | Finn Patrick John | -12,917 | $119.858 | $1,548,206 |
| 2026-08-18 | Finn Patrick John | -4,500 | $119.04 | $535,680 |
| 2026-08-18 | Finn Patrick John | -8,868 | $117.697 | $1,043,737 |
| 2026-08-18 | Finn Patrick John | -10,420 | $116.8202 | $1,217,266 |
| 2026-08-18 | Finn Patrick John | -33,354 | $115.899 | $3,865,695 |
| 2026-08-18 | Finn Patrick John | +23,355 | $67.85 | $1,584,637 |
| 2026-08-12 | Leproust Emily M. | -19,952 | - | - |
| 2026-08-12 | Leproust Emily M. | -19,952 | $125.0756 | $2,495,508 |
| 2026-08-12 | Leproust Emily M. | +19,952 | $26.66 | $531,920 |
| 2026-08-12 | BLAKE KATRYN | -2,240 | $122.88 | $275,251 |
| 2026-08-10 | Leproust Emily M. | -113,318 | - | - |
| 2026-08-10 | Leproust Emily M. | -113,318 | $125.1615 | $14,183,051 |
| 2026-08-10 | Leproust Emily M. | +113,318 | $26.66 | $3,021,058 |
| 2026-08-07 | CHESS ROBERT | -18,417 | - | - |
| 2026-08-07 | CHESS ROBERT | -18,417 | $110.89 | $2,042,261 |
| 2026-08-07 | CHESS ROBERT | +18,417 | $11.89 | $218,978 |
| 2026-08-05 | Cho Dennis | -14,205 | $109.75 | $1,558,999 |
| 2026-08-03 | Finn Patrick John | -2,888 | $85.3212 | $246,408 |
| 2026-08-03 | Green Paula | -1,133 | $85.3212 | $96,669 |
| 2026-08-03 | Leproust Emily M. | -5,101 | $85.3212 | $435,223 |
| 2026-08-03 | WERNER ROBERT F. | -167 | $85.3212 | $14,249 |
| 2026-08-03 | Cho Dennis | -1,070 | $85.3212 | $91,294 |
| 2026-07-23 | Finn Patrick John | -2,238 | $93.893 | $210,133 |
| 2026-07-09 | Laponis Adam | -2,399 | $94.334 | $226,307 |
| 2026-06-25 | Leproust Emily M. | -18,880 | $95 | $1,793,600 |
| 2026-06-24 | Cho Dennis | -14,205 | $89.75 | $1,274,899 |
| 2026-06-22 | Green Paula | -291 | $87.3224 | $25,411 |
| 2026-06-22 | Cho Dennis | -346 | $87.3224 | $30,214 |
| 2026-06-22 | Leproust Emily M. | -1,688 | $87.3224 | $147,400 |
| 2026-06-15 | Green Paula | -26,137 | - | - |
| 2026-06-15 | Green Paula | -2,028 | $82.1655 | $166,632 |
| 2026-06-15 | Green Paula | -24,109 | $81.6233 | $1,967,856 |
| 2026-06-15 | Green Paula | +26,137 | $23.33 | $609,776 |
| 2026-06-08 | Cho Dennis | -402 | $69.8442 | $28,077 |
| 2026-06-08 | Green Paula | -884 | $69.8442 | $61,742 |
| 2026-06-08 | Leproust Emily M. | -2,265 | $69.8442 | $158,197 |
| 2026-06-08 | WERNER ROBERT F. | -500 | - | - |
| 2026-06-08 | WERNER ROBERT F. | -1,127 | $69.07 | $77,842 |
| 2026-06-08 | WERNER ROBERT F. | -232 | $69.8442 | $16,204 |
| 2026-05-29 | Cho Dennis | -14,205 | $69.75 | $990,799 |
| 2026-05-29 | Laponis Adam | -4,000 | $70 | $280,000 |
| 2026-05-28 | Leproust Emily M. | -16,470 | - | - |
| 2026-05-28 | Leproust Emily M. | -6,465 | $68.6141 | $443,590 |
| 2026-05-28 | Leproust Emily M. | -7,623 | $67.9508 | $517,989 |
| 2026-05-28 | Leproust Emily M. | -900 | $66.8477 | $60,163 |
| 2026-05-28 | Leproust Emily M. | -1,482 | $65.3256 | $96,813 |
| 2026-05-28 | Leproust Emily M. | +16,470 | $8.82 | $145,265 |
| 2026-05-28 | Starovasnik Melissa A. | -2,500 | $68 | $170,000 |
| 2026-05-27 | Leproust Emily M. | +25,017 | - | - |
| 2026-05-27 | Leproust Emily M. | -1,265 | $66.2813 | $83,846 |
| 2026-05-27 | Leproust Emily M. | -23,752 | $65.2392 | $1,549,561 |
| 2026-05-27 | Leproust Emily M. | +25,017 | $8.82 | $220,650 |
| 2026-05-26 | Leproust Emily M. | +24,282 | - | - |
| 2026-05-26 | Leproust Emily M. | -24,282 | $65.0789 | $1,580,246 |
| 2026-05-26 | Leproust Emily M. | +24,282 | $8.82 | $214,167 |
| 2026-05-26 | WERNER ROBERT F. | -800 | $62.484 | $49,987 |
| 2026-05-26 | Starovasnik Melissa A. | -500 | $61.04 | $30,520 |
| 2026-05-21 | WERNER ROBERT F. | -688 | $53.257 | $36,641 |
| 2026-05-21 | Leproust Emily M. | -6,888 | $53.257 | $366,834 |
| 2026-05-21 | Laponis Adam | -2,019 | $53.257 | $107,526 |
| 2026-05-21 | Green Paula | -1,399 | $53.257 | $74,507 |
| 2026-05-21 | Finn Patrick John | -4,160 | $53.257 | $221,549 |
| 2026-05-21 | Cho Dennis | -1,642 | $53.257 | $87,448 |
| 2026-05-12 | JOHANNESSEN JAN | +12,000 | - | - |
| 2026-05-12 | JOHANNESSEN JAN | -12,000 | $56.12 | $673,440 |
| 2026-05-12 | JOHANNESSEN JAN | +12,000 | $14 | $168,000 |
| 2026-05-08 | WERNER ROBERT F. | -4,961 | $56.881 | $282,187 |
| 2026-05-04 | Cho Dennis | -1,962 | $57.1488 | $112,126 |
| 2026-05-04 | Leproust Emily M. | -5,127 | $57.1488 | $293,002 |
| 2026-05-04 | Finn Patrick John | -2,844 | $57.1488 | $162,531 |
| 2026-05-04 | Green Paula | -1,116 | $57.1488 | $63,778 |
| 2026-05-04 | WERNER ROBERT F. | -164 | $57.1488 | $9,372 |
| 2026-04-27 | Starovasnik Melissa A. | -500 | $61.83 | $30,915 |
| 2026-04-23 | Finn Patrick John | -2,321 | $60.761 | $141,026 |
| 2026-04-22 | Leproust Emily M. | +8,061 | - | - |
| 2026-04-22 | Leproust Emily M. | -151 | $66 | $9,966 |
| 2026-04-22 | Leproust Emily M. | -7,910 | $65.275 | $516,325 |
| 2026-04-22 | Leproust Emily M. | +8,061 | $8.82 | $71,098 |
| 2026-04-21 | Leproust Emily M. | +1,610 | - | - |
| 2026-04-21 | Leproust Emily M. | -1,610 | $65.01 | $104,666 |
| 2026-04-21 | Leproust Emily M. | +1,610 | $8.82 | $14,200 |
| 2026-04-17 | Laponis Adam | -4,000 | $60 | $240,000 |
| 2026-04-14 | Laponis Adam | -3,000 | $55 | $165,000 |
| 2026-04-09 | Laponis Adam | -2,597 | $49.889 | $129,562 |
| 2026-04-01 | Starovasnik Melissa A. | -1,000 | $51 | $51,000 |
| 2026-03-20 | Cho Dennis | -354 | $43.7864 | $15,500 |
| 2026-03-20 | Green Paula | -297 | $43.7864 | $13,005 |
| 2026-03-20 | Leproust Emily M. | -1,742 | $43.7864 | $76,276 |
| 2026-03-17 | CHESS ROBERT | -10,000 | - | - |
| 2026-03-17 | CHESS ROBERT | -10,000 | $47 | $470,000 |
| 2026-03-17 | CHESS ROBERT | +10,000 | $11.89 | $118,900 |
| 2026-03-06 | WERNER ROBERT F. | -246 | $46.426 | $11,421 |
| 2026-03-06 | Cho Dennis | -425 | $46.426 | $19,731 |
| 2026-03-06 | Green Paula | -935 | $46.426 | $43,408 |
| 2026-03-06 | Leproust Emily M. | -2,423 | $46.426 | $112,490 |
| 2026-02-23 | Green Paula | -1,465 | $46.7098 | $68,430 |
| 2026-02-23 | Cho Dennis | -844 | $46.7098 | $39,423 |
| 2026-02-23 | Finn Patrick John | -4,294 | $46.7098 | $200,572 |
| 2026-02-23 | WERNER ROBERT F. | -1,693 | $46.7098 | $79,080 |
| 2026-02-23 | Laponis Adam | -2,085 | $46.7098 | $97,390 |
| 2026-02-23 | Leproust Emily M. | -7,205 | $46.7098 | $336,544 |
| 2026-02-17 | Green Paula | -39,404 | $52.4 | $2,064,770 |
| 2026-02-17 | Finn Patrick John | -18,205 | - | - |
| 2026-02-17 | Finn Patrick John | -32,300 | - | - |
| 2026-02-17 | Finn Patrick John | -3,541 | $53.11 | $188,063 |
| 2026-02-17 | Finn Patrick John | -26,952 | $52.686 | $1,419,993 |
| 2026-02-17 | Finn Patrick John | -16,616 | $51.423 | $854,445 |
| 2026-02-17 | Finn Patrick John | -21,858 | $50.321 | $1,099,916 |
| 2026-02-17 | Finn Patrick John | +32,300 | $26.66 | $861,118 |
| 2026-02-17 | Finn Patrick John | +18,205 | $23.33 | $424,723 |
| 2026-02-13 | Finn Patrick John | -500 | - | - |
| 2026-02-13 | Finn Patrick John | -712 | - | - |
| 2026-02-13 | Finn Patrick John | -1,750 | $50.041 | $87,572 |
| 2026-02-13 | Finn Patrick John | +712 | $26.66 | $18,982 |
| 2026-02-13 | Finn Patrick John | +500 | $23.33 | $11,665 |
| 2026-02-13 | CHESS ROBERT | -2,184 | $48.261 | $105,402 |
| 2026-02-12 | Finn Patrick John | -1,000 | - | - |
| 2026-02-12 | Finn Patrick John | -1,500 | - | - |
| 2026-02-12 | Finn Patrick John | -3,500 | $50.225 | $175,788 |
| 2026-02-12 | Finn Patrick John | +1,500 | $26.66 | $39,990 |
| 2026-02-12 | Finn Patrick John | +1,000 | $23.33 | $23,330 |
| 2026-02-12 | Laponis Adam | -7,000 | $50 | $350,000 |
| 2026-02-11 | Cho Dennis | -5,000 | $49.93 | $249,650 |
| 2026-02-09 | WERNER ROBERT F. | -2,000 | - | - |
| 2026-02-06 | JOHANNESSEN JAN | -2,200 | $47.9067 | $105,395 |
| 2026-02-05 | Starovasnik Melissa A. | +5,095 | - | - |
| 2026-02-05 | BLAKE KATRYN | +5,095 | - | - |
| 2026-02-05 | Chan Nelson | +5,095 | - | - |
| 2026-02-05 | CHESS ROBERT | +5,095 | - | - |
| 2026-02-05 | JOHANNESSEN JAN | +5,095 | - | - |
| 2026-02-05 | RAGUSA ROBERT P | +5,095 | - | - |
| 2026-02-05 | CRANDELL KEITH | +5,095 | - | - |
| 2026-02-04 | WERNER ROBERT F. | -7,000 | $45.648 | $319,536 |
| 2026-02-03 | Leproust Emily M. | -5,001 | $46.576 | $232,927 |
| 2026-02-03 | WERNER ROBERT F. | -175 | $46.576 | $8,151 |
| 2026-02-03 | Green Paula | -1,194 | $46.576 | $55,612 |
| 2026-02-03 | Finn Patrick John | -2,705 | $46.576 | $125,988 |
| 2026-02-03 | Cho Dennis | -1,099 | $46.576 | $51,187 |
| 2026-01-23 | Finn Patrick John | -2,390 | $44.908 | $107,330 |
| 2026-01-13 | Laponis Adam | -3,000 | $40 | $120,000 |
| 2026-01-13 | Finn Patrick John | -3,279 | - | - |
| 2026-01-13 | Finn Patrick John | -23,279 | $40 | $931,160 |
| 2026-01-13 | Finn Patrick John | +3,279 | $8.82 | $28,921 |
| 2026-01-09 | Laponis Adam | -2,738 | $35.261 | $96,545 |
| 2025-12-22 | Green Paula | -273 | $34.556 | $9,434 |
| 2025-12-22 | Cho Dennis | -324 | $34.556 | $11,196 |
| 2025-12-22 | Leproust Emily M. | -1,605 | $34.556 | $55,462 |
| 2025-12-08 | Cho Dennis | -398 | $32.878 | $13,085 |
| 2025-12-08 | Leproust Emily M. | -2,255 | $32.878 | $74,140 |
| 2025-12-08 | Green Paula | -877 | $32.878 | $28,834 |
| 2025-12-08 | WERNER ROBERT F. | -230 | $32.878 | $7,562 |
| 2025-11-24 | WERNER ROBERT F. | -822 | $28.7095 | $23,599 |
| 2025-11-21 | Cho Dennis | -757 | $26.5035 | $20,063 |
| 2025-11-21 | Finn Patrick John | -1,776 | $26.5035 | $47,070 |
| 2025-11-21 | Green Paula | -598 | $26.5035 | $15,849 |
| 2025-11-21 | Laponis Adam | -887 | $26.5035 | $23,509 |
| 2025-11-21 | Leproust Emily M. | -2,663 | $26.5035 | $70,579 |
| 2025-11-21 | WERNER ROBERT F. | -229 | $26.5035 | $6,069 |
| 2025-11-18 | Leproust Emily M. | +146,914 | - | - |
| 2025-11-18 | Laponis Adam | +32,648 | - | - |
| 2025-11-18 | Finn Patrick John | +68,740 | - | - |
| 2025-11-18 | Cho Dennis | +25,465 | - | - |
| 2025-11-18 | Green Paula | +26,200 | - | - |
| 2025-11-18 | WERNER ROBERT F. | +16,324 | - | - |
| 2025-11-18 | JOHANNESSEN JAN | -7,044 | $24.77 | $174,480 |
| 2025-11-03 | Cho Dennis | -1,019 | $32.0794 | $32,689 |
| 2025-11-03 | Finn Patrick John | -2,755 | $32.0794 | $88,379 |
| 2025-11-03 | Green Paula | -1,084 | $32.0794 | $34,774 |
| 2025-11-03 | Leproust Emily M. | -4,887 | $32.0794 | $156,772 |
| 2025-11-03 | WERNER ROBERT F. | -160 | $32.0794 | $5,133 |
| 2025-10-30 | Cho Dennis | -6,515 | $31.4443 | $204,860 |
| 2025-10-30 | Finn Patrick John | -17,606 | $31.4443 | $553,608 |
| 2025-10-30 | Green Paula | -6,920 | $31.4443 | $217,595 |
| 2025-10-30 | Leproust Emily M. | -31,379 | $31.4443 | $986,691 |
| 2025-10-30 | Laponis Adam | -5,517 | $31.4443 | $173,478 |
| 2025-10-30 | WERNER ROBERT F. | -1,016 | $31.4443 | $31,947 |
| 2025-10-28 | WERNER ROBERT F. | +5,633 | - | - |
| 2025-10-28 | Finn Patrick John | +79,785 | - | - |
| 2025-10-28 | Cho Dennis | +29,518 | - | - |
| 2025-10-28 | Green Paula | +35,513 | - | - |
| 2025-10-28 | Leproust Emily M. | +168,976 | - | - |
| 2025-10-28 | Laponis Adam | +25,000 | - | - |
| 2025-10-23 | Finn Patrick John | -2,240 | $30.875 | $69,160 |
| 2025-10-09 | Laponis Adam | -2,517 | $32.922 | $82,865 |
| 2025-10-08 | Laponis Adam | -3,000 | $31.15 | $93,450 |
| 2025-10-06 | Laponis Adam | -5,875 | $32.187 | $189,099 |
| 2025-10-06 | Leproust Emily M. | -31,348 | $32.187 | $1,008,998 |
| 2025-10-06 | WERNER ROBERT F. | -2,041 | $32.187 | $65,694 |
| 2025-10-06 | Green Paula | -9,724 | $32.187 | $312,986 |
| 2025-10-06 | Finn Patrick John | -23,747 | $32.187 | $764,345 |
| 2025-10-06 | Cho Dennis | -3,876 | $32.187 | $124,757 |